- Home
- RGC vs PSNL Comparison
RGC vs PSNL Comparison
Compare RGC & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGC
- PSNL
- Stock Information
- Founded
- RGC 2014
- PSNL 2011
- Country
- RGC Hong Kong
- PSNL United States
- Employees
- RGC N/A
- PSNL N/A
- Industry
- RGC Medicinal Chemicals and Botanical Products
- PSNL Medical Specialities
- Sector
- RGC Health Care
- PSNL Health Care
- Exchange
- RGC Nasdaq
- PSNL Nasdaq
- Market Cap
- RGC 377.5M
- PSNL 426.6M
- IPO Year
- RGC 2021
- PSNL 2019
- Fundamental
- Price
- RGC $38.01
- PSNL $6.42
- Analyst Decision
- RGC
- PSNL Strong Buy
- Analyst Count
- RGC 0
- PSNL 5
- Target Price
- RGC N/A
- PSNL $8.00
- AVG Volume (30 Days)
- RGC 1.5M
- PSNL 922.2K
- Earning Date
- RGC 07-01-2025
- PSNL 08-06-2025
- Dividend Yield
- RGC N/A
- PSNL N/A
- EPS Growth
- RGC N/A
- PSNL N/A
- EPS
- RGC N/A
- PSNL N/A
- Revenue
- RGC N/A
- PSNL $85,694,000.00
- Revenue This Year
- RGC N/A
- PSNL $0.45
- Revenue Next Year
- RGC N/A
- PSNL $25.75
- P/E Ratio
- RGC N/A
- PSNL N/A
- Revenue Growth
- RGC N/A
- PSNL 15.57
- 52 Week Low
- RGC $0.08
- PSNL $1.14
- 52 Week High
- RGC $83.60
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- RGC 56.71
- PSNL 72.69
- Support Level
- RGC $15.12
- PSNL $6.06
- Resistance Level
- RGC $83.60
- PSNL $6.72
- Average True Range (ATR)
- RGC 10.44
- PSNL 0.44
- MACD
- RGC 3.76
- PSNL 0.10
- Stochastic Oscillator
- RGC 34.05
- PSNL 85.65
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.